Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
A simple blood test could detect Alzheimer’s disease with 100% accuracy, according to research from Resonant, a Utah biotech ...
BLUFFTON, S.C. (WCSC) - One of the first Alzheimer’s patients in the Lowcountry to take part in Leqembi infusion treatments ...
The EU recommends Anavex proceed with a full approval application for Alzheimer's drug Blarcamesine based on full Phase 2b/3 trial data. The U.S. FDA may grant accelerated approval to Anavex's ...
A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.
Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover the drug, I have met with Alzheimer’s patients and their loved ones who are anxious to ...
New treatments and tests for dementia are finally here, after decades of disappointments The post Dementia Breakthroughs ...
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
A small pharmaceutical company in Research Triangle Park is considering its next steps after seeing positive results in a clinical study evaluating its treatment for Alzheimer's disease.
One morning in October, US Army Colonel Victor Suarez finished his usual morning workout — a 32-mile bike ride — and then sat ...
The Alzheimer's Disease and Dementia Advisory Council wants state lawmakers to provide $300,000 in state funding for a public ...
Cleveland hospitals study whether new drug can prevent Alzheimer's 91.7 WVXU ... According to the FDA, the drug does come with possible side effects, including swelling or bleeding in the brain.
